StockData

Intuitive Surgical vs Smith & Nephew

ISRG and SNN side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ISRG and SNN compare

Intuitive Surgical grew revenue faster over the last twelve months (20.7% versus 6.1% for Smith & Nephew).

Intuitive Surgical scores higher on the StockData Score (17 against 6 for Smith & Nephew), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricISRGSNN
Size and price
Market cap$153B–
Share price$432.01$29.70
Change, 1 year−19.6%−17.0%
Change, 5 years18.4%−20.1%
Beta (5Y)1.330.63
Employees17K18K
StockData Score
Total score17 (better)6
Valuation score2 (better)0
Growth score4 (better)1
Performance score5 (better)1
Health score6 (better)4
Dividend score00
Valuation
P/E49.5×–
P/S13.8×–
P/B8.4×–
EV/EBITDA42.7×–
P/FCF47.4×–
PEG1.70–
FCF yield2.1%–
Fair value$350.05–
Margin of safety−23.4%–
Growth
Revenue growth (TTM)20.7% (better)6.1%
Revenue growth, 5Y average18.2% (better)6.2%
Net income growth (TTM)20.4%–
EPS growth (TTM)21.8%52.3% (better)
EPS growth, 5Y average21.8% (better)6.9%
Profitability
Gross margin66.7%68.0% (better)
Operating margin31.3% (better)12.9%
Net margin28.4%–
FCF margin29.2%–
Return on equity17.4%–
Return on invested capital22.5% (better)13.0%
Financial health
Debt / equity0.000.10 (better)
Net debt / EBITDA–−0.31
Interest coverage–5.7×
Current ratio4.96 (better)2.14
Altman Z-score37.48–
Piotroski F-score6–
Dividends and buybacks
Buyback yield2.3%–
Shareholder yield2.3%–
Ownership
Held by institutions86.9%4.2%
Held by insiders0.47%25.1%
Insider net buying, 12 months−$57.3M–
Superinvestors holding2–
Short interest, % of float2.1%–

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.